Diminished responsiveness of male homose
β
J. A. McDonald; L. Caruso; P. Karayiannis; L. J. Scully; J. R. W. Harris; G. E.
π
Article
π
1987
π
John Wiley and Sons
π
English
β 627 KB
In a randomized controlled trial, 41 chronic hepatitis B virus carriers were allocated, by opening numbered computerized randomization envelopes, to receive recombinant interferon-a2A at three different doses: 2.5; 5.0, and 10.0 mU per m2. Thirty-two patients received treatment (6 for 3 months, 26 f